Document is current
Any future updates will be listed below
-
Authors
Kemnitz, Jana https://orcid.org/0000-0003-0342-4952
Eckstein, Felix
Culvenor, Adam G.
Ruhdorfer, Anja
Dannhauer, Torben
Ring-Dimitriou, Susanne
Sänger, Alexandra M.
Wirth, Wolfgang
-
Funding
Funding for this research was provided by:
European Union Seventh Framework Programme (607510, 607510)
National Institutes of Health (N01-AR-2-2258; N01-AR-2-2259;N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262)
- License Information
-
More Information
Article History
Received: 28 September 2016
Revised: 7 April 2017
Accepted: 13 April 2017
First Online: 28 April 2017
Compliance with ethical standards
:
: Felix Eckstein is CEO of Chondrometrics GmbH, a company providing MR image analysis services to academic researchers and to industry. He has provided consulting services to Merck Serono, Mariel Therapeutics, Servier, and Bioclinica/Synarc, has prepared educational sessions for Medtronic, and has received research support from Pfizer, Eli Lilly, Merck Serono, GlaxoSmithKline, Centocor R&D, Wyeth, Novartis, Stryker, Abbvie, Kolon, Synarc, Ampio, BICL and Orthotrophix. Wolfgang Wirth has a part time employment with Chondrometrics GmbH and is a co-owner of Chondrometrics GmbH. No other authors declare a conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.
